Created at Source Raw Value Validated value
Oct. 26, 2020, 8:37 a.m. irct

[{"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - OtherControl group: This group will receive the Iranian nationally implemented treatment protocol of Covid-19, which include any of the following, Hydroxychloroquine 200mg po BD or Chlroquine Phosphate 250mg po BD, Lopinavir-Ritonavir po 400-100mg BD, Atazanavir-Ritanavir 100-300mg po daily, IFN \u03b2-1a 44mcg sc EOD for 5-7 doses, IFN \u03b2-1b 250mcg sc EOD for 5-7 doses, Dexamethasone 8mg iv daily for ten days, Heparin 5000 u sc TDS or Enoxaparin 60u sc daiy.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "TODO Treatment - OtherIntervention Group: In the intervention group in addition to the Iranian nationally implemented protocol of Covid-19 treatment (which include any of the following, Hydroxychloroquine 200mg po BD or Chlroquine Phosphate 250mg po BD, Lopinavir-Ritonavir po 400-100mg BD, Atazanavir-Ritanavir 100-300mg po daily, IFN \u03b2-1a 44mcg sc EOD for 5-7 doses, IFN \u03b2-1b 250mcg sc EOD for 5-7 doses, Dexamethasone 8mg iv daily for ten days, Heparin 5000 u sc TDS or Enoxaparin 60u sc daiy) will receive a thrice weekly -up to two weeks- of ozonization of 200 cc of patient blood drawn and mixed with three 40ml draws (equivalent to 120ml) of 30\u03bcg/mL of ozone gas over 5 min which is then transfused back into patient's blood stream over15 minutes.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 951, "treatment_name": "Ozonated autohemotherapy", "treatment_type": "Life support", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]